Jan. 27, 2020 Price forecast | 2 weeks: -3.30% | 1 month: -5.71% | 3 months: -4.77%


INMB stock forecast

Our latest prediction for INmune Bio, Inc.'s stock price was made on the Jan. 27, 2020 when the stock price was at 4.82$.

In the short term (2weeks), INMB's stock price should underperform the market by -3.30%. During that period the price should oscillate between -12.57% and +12.46%.

In the medium term (3months), INMB's stock price should underperform the market by -4.77%. During that period the price should oscillate between -43.46% and +32.26%.

Create a solid portfolio with INMB

Add INMB to your portfolio and optimize it!


About INmune Bio, Inc.

INmune Bio, Inc. focuses on controlling components of the immune system to activate an immune response against cancer and Alzheimer’s disease. Its product pipeline INKMUNE-Cancer, INB03-Cancer, XPRO1595-Alzheimer, and LIVNATE. The company was founded by Mark Lowdell in September 2015 and is headquartered in La Jolla, CA.

At the moment the company doesn't generate any revenue.

On its last earning announcement, the company reported a loss of -0.67$ per share.

The book value per share is 1.70$

INmune Bio, Inc. website


Three months stock forecastJan. 27, 2020


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
- - -7M - -7M -0.67 - - 11M 1.70 -5M - -5M